F Cavalli

585 total citations
42 papers, 366 citations indexed

About

F Cavalli is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, F Cavalli has authored 42 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 14 papers in Pathology and Forensic Medicine and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in F Cavalli's work include Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Lung Cancer Treatments and Mutations (8 papers). F Cavalli is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Lung Cancer Treatments and Mutations (8 papers). F Cavalli collaborates with scholars based in Switzerland, Italy and United States. F Cavalli's co-authors include Emanuele Zucca, Marcel Rozencweig, G. Bonadonna, L Tschopp, Andrea Zimmermann, E Pedrinis, Aron Goldhirsch, Roland Sonntag, Torben Skovsgaard and P. Dodion and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

F Cavalli

38 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Cavalli Switzerland 11 206 154 81 64 63 42 366
P. Dias Wickramanayake Germany 10 165 0.8× 149 1.0× 84 1.0× 60 0.9× 76 1.2× 22 400
A. Gottlieb United States 9 162 0.8× 231 1.5× 78 1.0× 109 1.7× 74 1.2× 11 451
S. D. Rowley United States 8 140 0.7× 139 0.9× 128 1.6× 28 0.4× 58 0.9× 11 436
K.G. van der Hem Netherlands 8 118 0.6× 119 0.8× 58 0.7× 41 0.6× 26 0.4× 16 268
T. K. Saikia India 8 153 0.7× 95 0.6× 45 0.6× 20 0.3× 80 1.3× 19 334
Vittorio Meneghini Italy 12 321 1.6× 174 1.1× 159 2.0× 42 0.7× 51 0.8× 21 516
Granada Perea Spain 8 91 0.4× 74 0.5× 51 0.6× 65 1.0× 37 0.6× 12 278
Ilaria Proserpio Italy 8 210 1.0× 136 0.9× 83 1.0× 87 1.4× 149 2.4× 16 453
Bodey Gp United States 8 189 0.9× 163 1.1× 121 1.5× 20 0.3× 51 0.8× 10 380
Geundoo Jang South Korea 12 117 0.6× 208 1.4× 35 0.4× 32 0.5× 159 2.5× 39 396

Countries citing papers authored by F Cavalli

Since Specialization
Citations

This map shows the geographic impact of F Cavalli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Cavalli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Cavalli more than expected).

Fields of papers citing papers by F Cavalli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Cavalli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Cavalli. The network helps show where F Cavalli may publish in the future.

Co-authorship network of co-authors of F Cavalli

This figure shows the co-authorship network connecting the top 25 collaborators of F Cavalli. A scholar is included among the top collaborators of F Cavalli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Cavalli. F Cavalli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conconi, Annarita, Catherine Thiéblemont, Luciano Cascione, et al.. (2020). Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment. Haematologica. 105(11). 2592–2597. 27 indexed citations
2.
Cavalli, F. (2002). Hodgkin's disease: treatment of relapsed disease. Annals of Oncology. 13. 159–162. 7 indexed citations
3.
Bertoni, Francesco, Emanuele Zucca, Davide Genini, et al.. (1999). Immunoglobulin Light Chain Kappa Deletion Rearrangement as a Marker of Clonality in Mantle Cell Lymphoma. Leukemia & lymphoma. 36(1-2). 147–150. 10 indexed citations
4.
Bertoni, Francesco, et al.. (1999). Clonality Assessment in Blood of Patients with Mantle Cell Lymphoma. Leukemia & lymphoma. 32(3-4). 375–379. 10 indexed citations
5.
Betticher, Daniel, A. von Rohr, Daniel Ratschiller, et al.. (1998). Fewer infections, but maintained antitumor activity with lower-dose versus standard-dose cladribine in pretreated low-grade non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 16(3). 850–858. 23 indexed citations
6.
Roth, A, Giovanni Martinelli, Nicola Fazio, et al.. (1997). Taxotere-cisplatin (TC) in advanced gastric carcinoma (AGC): A promising drug combination. European Journal of Cancer. 33. S275–S276. 2 indexed citations
7.
Neuenschwander, H., Éduardo Bruera, & F Cavalli. (1997). Matching the clinical function and symptom status with the expectations of patients with advanced cancer, their families, and health care workers. Supportive Care in Cancer. 5(3). 252–256. 9 indexed citations
8.
Sessa, Cristiana, et al.. (1990). A phase II study of iproplatin in advanced or metastatic stomach cancer. European Journal of Cancer and Clinical Oncology. 26(1). 61–62. 1 indexed citations
9.
10.
Cavalli, F, et al.. (1986). Prednimustine: the rationale for clinical development.. PubMed. 13(1 Suppl 1). 1–2. 2 indexed citations
11.
Joss, R, et al.. (1984). [Extrapulmonary small-cell carcinoma - a rarity with important therapeutic consequences].. PubMed. 114(5). 161–6. 8 indexed citations
12.
Cavalli, F, Aron Goldhirsch, & R Joss. (1982). Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancer. 1. 164–167.
13.
Sessa, C., et al.. (1982). [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].. PubMed. 112(26). 930–3. 2 indexed citations
14.
Maddox, Yvonne T., et al.. (1981). Medical and scientific meetings. Cancer. 47(12). A32–A33. 1 indexed citations
15.
Goldhirsch, Aron, et al.. (1979). Warthin's tumor with Sjögren's syndrome and non-Hodgkin's lymphoma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 58(8). 345–50. 19 indexed citations
16.
Cavalli, F, et al.. (1978). A case of liver toxicity following cis-dichlorodiammineplatinum(II) treatment.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 62(12). 2125–6. 36 indexed citations
17.
Cavalli, F, Roland Sonntag, & Kurt Brunner. (1977). ACUTE LEUKAEMIA IN HODGKIN'S DISEASE. Scandinavian Journal of Haematology. 19(3). 319–320. 5 indexed citations
18.
Cavalli, F, et al.. (1977). Akute myeloische Leukämie im Krankheitsverlauf des Morbus Hodgkin. DMW - Deutsche Medizinische Wochenschrift. 102(28). 1019–1024. 7 indexed citations
19.
20.
Cavalli, F, C. Sauter, H. J. Senn, & P. Alberto. (1976). [The treatment of acute myelocytic leukemia during the first recurrence by means of a new cytostatic combination].. PubMed. 106(38). 1265–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Dias Wickramanayake Breakdown of academic impact, for papers by A. Gottlieb Breakdown of academic impact, for papers by S. D. Rowley Breakdown of academic impact, for papers by K.G. van der Hem Breakdown of academic impact, for papers by T. K. Saikia Breakdown of academic impact, for papers by Vittorio Meneghini Breakdown of academic impact, for papers by Granada Perea Breakdown of academic impact, for papers by Ilaria Proserpio Breakdown of academic impact, for papers by Bodey Gp Breakdown of academic impact, for papers by Geundoo Jang
Rankless by CCL
2026